Appointments
Rahul Guha appointed MD & CEO of API Holdings
Rahul Guha to lead both API Holdings and Thyrocare Technologies, driving strategic alignment and operational synergies across group companies.
In a significant leadership development, Thyrocare Technologies has announced that its Managing Director and Chief Executive Officer, Rahul Guha, has been entrusted with an additional responsibility as the Managing Director and CEO of API Holdings Limited, the ultimate holding company of Thyrocare. The appointment will take effect from August 27, 2025.
The decision was communicated through an official intimation from API Holdings dated August 6, 2025. It was based on the recommendation of API’s Nomination and Remuneration Committee and subsequently approved by the Board of Directors of API.
Guha’s elevation comes as part of the group's broader strategy to foster strong, integrated leadership across its companies. Importantly, he will continue to serve as MD & CEO of API Holdings managing both roles concurrently. This dual leadership is expected to strengthen collaboration and operational alignment between Thyrocare and its parent company, contributing to long-term value creation and accelerated growth.
Before assuming his current role at Thyrocare, Guha held the position of President – Operations at API Holdings and was also a Key Managerial Personnel (KMP) within the organisation. During this tenure, he was instrumental in driving strategic synergies across API and its group entities, streamlining operations and creating a unified vision across the healthcare ecosystem.
This leadership transition marks a new phase of integrated growth for the group, focused on operational efficiency, innovation, and a strengthened focus on delivering quality and accessible healthcare services to millions of customers across India.
Topics
Author
Loading...
Loading...